<bill session="115" type="s" number="974" updated="2019-04-26T14:00:49Z">
  <state datetime="2018-06-14">REPORTED</state>
  <status>
    <unknown datetime="2018-06-14"/>
  </status>
  <introduced datetime="2017-04-27"/>
  <titles>
    <title type="official" as="introduced">A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.</title>
    <title type="short" as="reported to senate">CREATES Act of 2017</title>
    <title type="short" as="reported to senate">CREATES Act of 2018</title>
    <title type="short" as="reported to senate">CREATES Act of 2018</title>
    <title type="short" as="reported to senate">Creating and Restoring Equal Access To Equivalent Samples Act of 2017</title>
    <title type="short" as="reported to senate">Creating and Restoring Equal Access to Equivalent Samples Act of 2018</title>
    <title type="short" as="reported to senate">Creating and Restoring Equal Access to Equivalent Samples Act of 2018</title>
    <title type="short" as="introduced">CREATES Act of 2017</title>
    <title type="short" as="introduced">CREATES Act of 2017</title>
    <title type="short" as="introduced">Creating and Restoring Equal Access To Equivalent Samples Act of 2017</title>
    <title type="short" as="introduced">Creating and Restoring Equal Access To Equivalent Samples Act of 2017</title>
    <title type="display">Creating and Restoring Equal Access to Equivalent Samples Act of 2018</title>
  </titles>
  <sponsor bioguide_id="L000174"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2018-03-12"/>
    <cosponsor bioguide_id="B001277" joined="2017-04-27"/>
    <cosponsor bioguide_id="B001288" joined="2018-08-22"/>
    <cosponsor bioguide_id="B000944" joined="2018-04-12"/>
    <cosponsor bioguide_id="C001035" joined="2017-04-27"/>
    <cosponsor bioguide_id="C001095" joined="2017-04-27"/>
    <cosponsor bioguide_id="C001098" joined="2017-12-05"/>
    <cosponsor bioguide_id="D000618" joined="2018-03-12"/>
    <cosponsor bioguide_id="D000563" joined="2017-04-27"/>
    <cosponsor bioguide_id="E000295" joined="2018-06-12"/>
    <cosponsor bioguide_id="F000062" joined="2017-04-27"/>
    <cosponsor bioguide_id="F000463" joined="2018-08-22"/>
    <cosponsor bioguide_id="G000359" joined="2018-04-12"/>
    <cosponsor bioguide_id="G000386" joined="2017-04-27"/>
    <cosponsor bioguide_id="H001076" joined="2017-12-18"/>
    <cosponsor bioguide_id="K000393" joined="2018-02-05"/>
    <cosponsor bioguide_id="K000383" joined="2018-03-12"/>
    <cosponsor bioguide_id="K000367" joined="2017-04-27"/>
    <cosponsor bioguide_id="L000577" joined="2017-04-27"/>
    <cosponsor bioguide_id="M000303" joined="2017-04-27"/>
    <cosponsor bioguide_id="M001170" joined="2017-04-27"/>
    <cosponsor bioguide_id="M000639" joined="2018-06-12"/>
    <cosponsor bioguide_id="M001153" joined="2018-03-12"/>
    <cosponsor bioguide_id="P000603" joined="2017-12-18"/>
    <cosponsor bioguide_id="R000605" joined="2018-05-24"/>
    <cosponsor bioguide_id="S001203" joined="2018-02-06"/>
    <cosponsor bioguide_id="S000770" joined="2018-05-22"/>
    <cosponsor bioguide_id="T000464" joined="2018-05-24"/>
    <cosponsor bioguide_id="W000802" joined="2017-04-27"/>
    <cosponsor bioguide_id="Y000064" joined="2018-05-22"/>
  </cosponsors>
  <actions>
    <action datetime="2017-04-27">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-04-27" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
      <reference ref="CR S2619" label="Sponsor introductory remarks on measure"/>
    </action>
    <calendar datetime="2018-06-14" state="REPORTED">
      <text>Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </calendar>
    <action datetime="2018-06-21">
      <text>Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.</text>
    </action>
    <calendar datetime="2018-06-21" calendar="Senate Legislative" under="General Orders" number="482">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.</text>
    </calendar>
  </actions>
  <committees>
    <committee subcommittee="" code="SSJU" name="Senate Judiciary" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="identical" number="2212"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Civil actions and liability"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
    <term name="Product development and innovation"/>
  </subjects>
  <amendments/>
  <summary date="2017-04-27T04:00:00Z" status="Introduced in Senate">Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017

This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.</summary>
  <committee-reports/>
</bill>
